{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:22:05Z","timestamp":1791199325099,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008452.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000}}],"reference-count":96,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008452.pub4","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T08:44:49Z","timestamp":1471509889000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hormonal contraceptives for contraception in overweight or obese women"],"prefix":"10.1002","volume":"2016","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[{"name":"FHI 360; Clinical and Epidemiological Sciences; 359 Blackwell St, Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Bernholc","sequence":"additional","affiliation":[{"name":"FHI 360; Biostatistics; 359 Blackwell St, Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Chen","sequence":"additional","affiliation":[{"name":"FHI 360; Biostatistics; 359 Blackwell St, Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W","family":"Grey","sequence":"additional","affiliation":[{"name":"FHI 360; Social and Behavioral Health Sciences; 359 Blackwell St, Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Otterness","sequence":"additional","affiliation":[{"name":"Global Health Access Program; Mae Sot Tak Thailand 63110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Westhoff","sequence":"additional","affiliation":[{"name":"Columbia University; Dept of Obstetrics and Gynecology; 630 West 168 Street New York New York USA NY 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edelman","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University; Dept. of Obstetrics and Gynecology; Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Dept. of Clinical Epidemiology; PO Box 9600 Albinusdreef 2 Leiden Netherlands NL 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2008.12.013","article-title":"Association between efficacy and body weight or body mass index for two low-dose oral contraceptives","volume":"79","author":"Burkman","year":"2009","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(01)00214-1","article-title":"Comparison of a novel norgestimate\/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1\/20","volume":"63","author":"Hampton","year":"2001","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2008.02.007","article-title":"Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives","volume":"77","author":"Hampton","year":"2008","journal-title":"Contraception"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD008452.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1097\/00006250-200604001-00117","article-title":"Higher body weight and body mass index are not associated with reduced efficacy in Ortho Tri-Cyclen Lo users (abstract)","volume":"107","author":"Zhang","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD008452.pub4-BIB0005|cit5","first-page":"e0135309","article-title":"The effect of age, parity and body mass index on the efficacy, safety, placement and user satisfaction associated with two low-dose levonorgestrel intrauterine contraceptive Systems: subgroup analyses of data from a Phase III trial","volume":"10","author":"Gemzell-Danielsson","year":"2015","journal-title":"PloS Pne"},{"issue":"S1","key":"10.1002\/14651858.CD008452.pub4-BIB0006|cit6","first-page":"S191","article-title":"Efficacy and safety of two low-dose levonorgestrel intrauterine systems according to women's age: a global, multicentre, open-label, randomized 3-year Phase III Pearl Index study (conference poster abstract)","volume":"18","author":"Kaunitz","year":"2013","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0010-7824(00)10782-N","article-title":"Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience","volume":"52","author":"Grubb","year":"1995","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0010-7824(95)00141-7","article-title":"Effectiveness of Norplant implants through seven years: a large-scale study in China","volume":"52","author":"Gu","year":"1995","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub4-BIB0010|cit10","first-page":"673","article-title":"A 5-year evaluation of NORPLANT contraceptive implants in China","volume":"83","author":"Gu","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"318.e1","DOI":"10.1016\/j.ajog.2014.09.014","article-title":"Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women","volume":"212","author":"Kaunitz","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2014.11.011","article-title":"Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill","volume":"91","author":"Kaunitz","year":"2015","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD008452.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AOG.0000000000000095","article-title":"Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial","volume":"123","author":"Kaunitz","year":"2014","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0015|cit15","unstructured":"Mansour D Sundstrom Poromaa I Sommer W Korver T Effect of body mass index and age on the contraceptive effectiveness of nomegestrol acetate\/17beta-oestradiol and drospirenone\/ethinylestradiol European Journal of Contraception and Reproductive Health Care 2012 S95"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Mansour D Verhoeven C Sommer W Weisberg E Taneepanichskul S Melis GB Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen European Journal of Contraception and Reproductive Health Care 2011 430 43","DOI":"10.3109\/13625187.2011.614029"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e3182a1741c","article-title":"Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive","volume":"122","author":"Archer","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2015.09.013","article-title":"Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive","volume":"93","author":"Nakajima","year":"2016","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(98)00112-7","article-title":"Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic","volume":"58","author":"Sivin","year":"1998","journal-title":"Contraception"},{"issue":"12","key":"10.1002\/14651858.CD008452.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1093\/humrep\/13.12.3371","article-title":"The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study","volume":"13","author":"Sivin","year":"1998","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0010-7824(96)00275-2","article-title":"Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0024|cit24","first-page":"337","article-title":"Levonorgestrel capsule implants in the United States: a 5-year study","volume":"92","author":"Sivin","year":"1998","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2009.07.003","article-title":"The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol","volume":"81","author":"Kroll","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Westhoff CL Hait HI Reape KZ Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive Contraception 2012 235 9","DOI":"10.1016\/j.contraception.2011.08.001"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(90)90143-J","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Secura GM Allsworth JE Madden T Mullersman JL Peipert JF The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception American Journal of Obstetrics and Gynecology 2010 115 e1-7","DOI":"10.1016\/j.ajog.2010.04.017"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Xu H Wade JA Peipert JF Zhao Q Madden T Secura GM Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women Obstetrics and Gynecology 2012 21 6","DOI":"10.1097\/AOG.0b013e318259565a"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0032|cit32","unstructured":"Yamazaki M Dwyer K Sohban M Davis D Kim MJ Soule L Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis Contraception"},{"issue":"18","key":"10.1002\/14651858.CD008452.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"Journal of the American Medical Association"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub4-BIB0034|cit34","first-page":"799","article-title":"Efficacy and safety of a transdermal contraceptive system","volume":"98","author":"Smallwood","year":"2001","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD008452.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Banerjee SK Baweja R Bhatt RV Chatterjee A Choudhury SD Coyaji B Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception Contraception 1984 561 74","DOI":"10.1016\/0010-7824(84)90006-4"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Berenson AB van den Berg P Williams KJ Rahman M Effect of injectable and oral contraceptives on glucose and insulin levels Obstet Gynecol 2011 41 7","DOI":"10.1097\/AOG.0b013e318202ac23"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Casey PM Long ME Marnach ML Bury JE Bleeding related to etonogestrel subdermal implant in a US population Contraception 2011 426 30","DOI":"10.1016\/j.contraception.2010.09.012"},{"issue":"12","key":"10.1002\/14651858.CD008452.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-2008-1026401","article-title":"[Incidence of side effects caused by a three-stage preparation administered to 10,034 women]","volume":"50","author":"Cirkel","year":"1991","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Du MK Chow LP Zheng HM Chen CH A 10-year follow-up study of contraceptive Norplant implants International Journal of Gynaecology & Obstetrics 2000 249 56","DOI":"10.1016\/S0020-7292(99)00214-3"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Du MK Zheng HM Chen HC Chow LP Study of Norplant implants in Shanghai: three-year experience International Journal of Gynaecology & Obstetrics 1990 345 57","DOI":"10.1016\/0020-7292(90)90521-L"},{"issue":"12","key":"10.1002\/14651858.CD008452.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1185\/03007995.2015.1094455","article-title":"Impact of bodyweight\/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials","volume":"31","author":"Gemzell-Danielsson","year":"2015","journal-title":"Current Medical Research and Opinion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008452.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon\u00ae: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Glasier A Cameron ST Blithe D Scherrer B Mathe H Levy D Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel Contraception 2011 363 7","DOI":"10.1016\/j.contraception.2011.02.009"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2014.11.001","article-title":"Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception","volume":"91","author":"Kapp","year":"2015","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e31828317cc","article-title":"Contraceptive failures in overweight and obese combined hormonal contraceptive users","volume":"121","author":"McNicholas","year":"2013","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Moreau C Trussell J Results from pooled Phase III studies of ulipristal acetate for emergency contraception Contraception 2012","DOI":"10.1016\/j.contraception.2012.05.012"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Mornar S Chan L-N Mistretta S Neustadt A Martins S Gilliam M Pharmacokinetics of the etonogestrel contraceptive implant in obese women American Journal of Obstetrics and Gynecology August 2012 e1 6","DOI":"10.1016\/j.ajog.2012.05.002"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0050|cit50","unstructured":"Neustadt A Gilliam M Pharmacokinetics of Implanon in obese women http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00724438"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/1966493","article-title":"International experience with NORPLANT\u00ae and NORPLANT\u00ae-2 contraceptives","volume":"19","author":"Sivin","year":"1988","journal-title":"Studies in Family Planning"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Sivin I Mishell DR Diaz S Biswas A Alvarez F Darney P Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study Contraception 2000 187 94","DOI":"10.1016\/S0010-7824(00)00095-0"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(99)00035-9","article-title":"Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0054|cit54","unstructured":"American Society for Emergency Contraception Efficacy of emergency contraception and body weight: Current understanding and recommendations http:\/\/americansocietyforec.org\/uploads\/3\/2\/7\/0\/3270267\/asec_ec_efficacy_and_weight_statement.pdf"},{"issue":"8","key":"10.1002\/14651858.CD008452.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina","volume":"16","author":"Brunner Huber","year":"2006","journal-title":"Annals of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD008452.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2004.10.009","article-title":"The role of body weight in oral contraceptive failure: results from the 1995 National Survey of Family Growth","volume":"15","author":"Brunner","year":"2005","journal-title":"Annals of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008452.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.contraception.2014.05.005","article-title":"Factors associated with lack of effective contraception among obese women in the United States","volume":"90","author":"Callegari","year":"2014","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0059|cit59","unstructured":"Centers for Disease Control and Prevention Defining Adult Overweight and Obesity www.cdc.gov\/obesity\/adult\/defining.html"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1097\/01.AOG.0000463238.63321.bd","article-title":"Levonorgestrel levels in nonobese and obese women using LNG20, a new intrauterine contraceptive","volume":"125 Suppl 1","author":"Creinin","year":"2015","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"263.e1","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"Dinger","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Dinger J Minh TD Buttmann N Bardenheuer K Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen Obstetrics and Gynecology 2011 33 40","DOI":"10.1097\/AOG.0b013e31820095a2"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0063|cit63","unstructured":"European Consortium for Emergency Contraception Efficacy of emergency contraception and body weight. Current understanding and recommendations www.ec-ec.org\/custom-content\/uploads\/2015\/12\/ECEC-EC-Body-Weight-November-2015.pdf"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003987.pub5","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0067|cit67","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE Handbook [updated October 2013] http:\/\/gdt.guidelinedevelopment.org\/central_prod\/_design\/client\/handbook\/handbook.html"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.fertnstert.2009.12.054","article-title":"Surrogate end points in women's health research: science, protoscience, and pseudoscience","volume":"93","author":"Grimes","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0070|cit70","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub4-BIB0071|cit71","first-page":"820","article-title":"Body weight and risk of oral contraceptive failure","volume":"99","author":"Holt","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":"Body mass index, weight, and oral contraceptive failure risk","volume":"105","author":"Holt","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0073|cit73","unstructured":"Jatlaoui TC Curtis KM Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review Contraception"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0000000000001094","article-title":"Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009-2012","volume":"126","author":"Kavanaugh","year":"2015","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2015.02.006","article-title":"Weight and body mass index among female contraceptive clients","volume":"91","author":"Kohn","year":"2015","journal-title":"Contraception"},{"issue":"7","key":"10.1002\/14651858.CD008452.pub4-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008815.pub3","article-title":"Progestin-only contraceptives: effects on weight","author":"Lopez","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub4-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006133.pub5","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/13625187.2015.1023893","article-title":"The relationship between unplanned pregnancy and maternal body mass index 2009-2012","volume":"20","author":"McKeating","year":"2015","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/13625187.2014.960561","article-title":"European society of contraception statement on contraception in obese women","volume":"20","author":"Merki-Feld","year":"2015","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2015.11.005","article-title":"Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year","volume":"93","author":"Morrell","year":"2016","journal-title":"Contraception"},{"issue":"9945","key":"10.1002\/14651858.CD008452.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD008452.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the united states, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0085|cit85","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.contraception.2008.11.017","article-title":"Obesity and oral contraceptive pill failure","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0087|cit87","unstructured":"United Nations Department of Economic and Social Affairs World Contraceptive Patterns 2015 www.un.org\/en\/development\/desa\/population\/publications\/"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1783\/147118901101195092","article-title":"Oral contraceptive failures and body weight: findings in a large cohort study","volume":"27","author":"Vessey","year":"2001","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0089|cit89","unstructured":"GA Wells Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD008452.pub4-BIB0090|cit90","first-page":"56S","article-title":"Higher body weight does not affect NuvaRing's efficacy (abstract)","volume":"105","author":"Westhoff","year":"2005","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.contraception.2008.04.009","article-title":"Subject weight and oral contraceptive efficacy in recent clinical trials (abstract)","volume":"78","author":"Westhoff","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.contraception.2009.05.061","article-title":"Ovarian suppression during oral contraceptive use in normal-weight and obese women","volume":"80","author":"Westhoff","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"Westhoff","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.contraception.2014.04.018","article-title":"Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol\/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles","volume":"90","author":"Westhoff","year":"2014","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub4-BIB0096|cit96","unstructured":"World Health Organization Obesity http:\/\/www.euro.who.int\/en\/what-we-do\/health-topics\/noncommunicable-diseases\/obesity"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008452.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:17:21Z","timestamp":1744247841000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008452.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":96,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008452.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}